Evidence map›Paper›PMID 21210795›Full record

ArticleHealth services research2011

Underutilization of the AIDS Drug Assistance Program: associated factors and policy implications.

Noah C Godwin, James H Willig, Christa R Nevin, Hui-Yi Lin, Jeroan Allison, Kathy Gaddis, Jennifer Peterson, Michael S Saag, Michael J Mugavero, James L Raper

Abstract read
In one paragraph

Article in Health services research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Personalized therapeutics: a potential threat to health equity.Journal of general internal medicine · 2012
    Article
  4. A qualitative study of underutilization of the AIDS drug assistance program.The Journal of the Association of Nurses in AIDS Care : JANAC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Noah C GodwinUniversity of Alabama School of Medicine, 908 20th St. South, Birmingham, AL 35294, USA. noahg@uab.edu
James H Willig
Christa R Nevin
Hui-Yi Lin
Jeroan Allison
Kathy Gaddis
Jennifer Peterson
Michael S Saag
Michael J Mugavero
James L Raper

Funding

Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
UAB Short-Term Research Training in Health Professional Schools (SHRT)T35HL007473 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAM M GEISLER · 1985 to 2026
$4.0M
Adherence to HIV Care: Advancing the ScienceK23MH082641 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MUGAVERO, MICHAEL J · 2008 to 2012
$966k
NHLBI NIH HHS T35 HL007473NIAID NIH HHS 1 R24 AI067039-1NIAID NIH HHS P30 AI027767NIAID NIH HHS P30-AI27767NIAID NIH HHS R24 AI067039NIMH NIH HHS K23 MH082641NIMH NIH HHS K23MH082641
6 · The paper itself

Abstract

backgroundThe AIDS Drug Assistance Program (ADAP) provides antiretroviral medications to low-income individuals with HIV infection.

methodsA prospective cohort study of ADAP utilization, measured using medication possession ratio (MPR), was conducted during the 2008 calendar year at the University of Alabama at Birmingham 1917 HIV Clinic. Multivariable ordinal logistic regression evaluated factors associated with ADAP utilization.

resultsAmong 245 patients, MPR quartiles (Q) were the following: Q1<69 percent, Q2=69-83 percent, Q3=84-93 percent, Q4>93 percent. In ordinal logistic regression, younger age (OR=0.59 per 10 years; 95 percent CI=0.44-0.79), nonwhite males (2.18; 1.18-4.04), lower CD4 count (2.79 for <200 cells/mm(3) ; 1.44-5.43), and a history of alcohol abuse (2.11; 1.02-4.37) were associated with poor ADAP utilization.

conclusionsOne quarter of ADAP enrollees had MPR below 69 percent, a level well below that associated with optimal HIV treatment outcomes, indicating a need for programmatic interventions to improve ADAP utilization.

Indexed as

Medication AdherenceAdultAlabamaAnti-HIV AgentsFemaleHealth PolicyHIV InfectionsHumansInsurance, Pharmaceutical ServicesLogistic ModelsMaleMedical AssistanceMultivariate AnalysisProspective StudiesRisk FactorsAnti-HIV Agents

Identifiers

PMID21210795
PMCPMC3097412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.